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Large-Scale Screening of Preferred
Interactions of Human Src Homology-3 (SH3)
Domains Using Native Target Proteins as
Affinity Ligands*□
S

Arunas Kazlauskas‡储**, Constanze Schmotz‡储, Tapio Kesti‡, Jussi Hepojoki‡,
Iivari Kleino‡, Tomonori Kaneko§, Shawn S.C. Li§, and Kalle Saksela‡¶
The Src Homology-3 (SH3) domains are ubiquitous protein
modules that mediate important intracellular protein interactions via binding to short proline-rich consensus motifs in their target proteins. The affinity and specificity of
such core SH3 - ligand contacts are typically modest, but
additional binding interfaces can give rise to stronger and
more specific SH3-mediated interactions. To understand
how commonly such robust SH3 interactions occur in the
human protein interactome, and to identify these in an
unbiased manner we have expressed 324 predicted human SH3 ligands as full-length proteins in mammalian
cells, and screened for their preferred SH3 partners using
a phage display-based approach. This discovery platform
contains an essentially complete repertoire of the ⬃300
human SH3 domains, and involves an inherent binding
threshold that ensures selective identification of only SH3
interactions with relatively high affinity. Such strong and
selective SH3 partners could be identified for only 19 of
these 324 predicted ligand proteins, suggesting that the
majority of human SH3 interactions are relatively weak,
and thereby have capacity for only modest inherent selectivity. The panel of exceptionally robust SH3 interactions identified here provides a rich source of leads and
hypotheses for further studies. However, a truly comprehensive characterization of the human SH3 interactome
will require novel high-throughput methods based on
function instead of absolute binding affinity. Molecular &
Cellular Proteomics 15: 10.1074/mcp.M116.060483, 3270–
3281, 2016.
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The Src Homology-3 (SH3)1 domain is one of the most
common modular domains in eukaryotic genomes. SH3 domains serve to guide interaction of proteins that typically are
involved in regulation of cell growth and differentiation, and
are often involved in pathogenesis of diseases such as cancer
(1–3). In addition, microbial pathogens, such as HIV, can
exploit SH3-mediated cellular processes (4 – 6). Human proteome contains ⬃300 different SH3 domains and many more
SH3 ligand proteins, creating an enormous number of theoretically possible SH3 interactions. Knowing which particular
of these interactions actually take place and are biologically
meaningful would greatly increase our understanding about
the signaling networks that regulate normal cellular behavior
and become deregulated in many important diseases.
SH3 domains are relatively short (⬃60 residues) modules
that are specialized in binding to proline-rich target peptides
(7–9). These peptides typically contain a PxxP core-binding
motif (where x is any amino acid) flanked by a basic residue on
either side of the PxxP motif, but a large number and variety
of unconventional SH3 target motifs have also been identified
(9). A shallow groove on the surface of SH3 domains formed
by a set of conserved hydrophobic residues is adapted to
bind to these target peptides. Additional contacts between
variable SH3 loop regions and ligand residues outside of the
PxxP motif can be critical in determining the specificity and
affinity of binding. The capacity of such complex molecular
interactions to contribute to the strength and selectivity of
SH3 binding has been highlighted by structural and biochemical studies on recruitment of the SH3 domain of the tyrosine
kinase Hck by the HIV-1 pathogenicity factor Nef (10, 11).
However, it is unclear how common such strong and specific
SH3 binding is in nature. In other words, it is not known how
many of all SH3/ligand complexes involved in guiding of eukaryotic protein interactions actually play a dominant role in
defining these partnerships. Indeed, it can be envisioned that
in many cases SH3-target peptide contacts play more subtle
1
The abbreviations used are: SH3, Src Homology-3; ROS, reactive
oxygen species; PPI, protein-protein interaction; cfu, colony forming
units; Y2H, yeast two-hybrid.
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roles in coordinating the architecture of protein complexes,
and despite being important for cellular regulation do not
need to involve high binding affinities or great inherent
selectivity.
We have developed an experimental platform for unbiased
and comprehensive identification of preferred interactions between SH3 domains and their ligand proteins. This approach
is based on the use of a phage-display library containing a
virtually complete collection of human SH3 domains (n ⫽ 296)
(12). This system allows an unbiased identification of the SH3
domains that show preferential binding to ligand proteins of
interests. Because these target proteins are expressed in their
native form, this system has the potential to explore binding
affinity and specificity contributed by contacts provided by
the peptide binding interface, as well as more complex and
atypical interactions. The binding affinity required for positive
identification of a specific interaction in this discovery system
is relatively high (estimated to be in the range of 2 to 5 M), as
interactions with dissociation constants higher than 5 M are
rarely found (12–25) and unpublished observations). Although
this may be seen as a technical limitation when considering
that many SH3 interactions with established roles in cell biology are weak such an affinity threshold is also a major experimental advantage by filtering out nonspecific background
caused by promiscuous low affinity binding that most SH3
domains exhibit toward a variety of proline-rich sequences.
The possibility to use native SH3 ligand proteins as “baits,”
and the capacity to interrogate the complete SH3 repertoire in
parallel, combined with the virtually complete lack of confounding variables unrelated to binding affinity provide this
approach with distinct advantages over other experimental
systems, such as yeast two-hybrid (Y2H) and peptide array
screening that have been actively used to decipher SH3 mediated protein interaction networks (26 –33).
Our earlier work on a variety of individual ligand proteins of
interest has established the value of this phage library in
identifying SH3-mediated interactions that involve distinct affinity and selectivity (12–22). In this study we apply recombination-mediated cloning for expression of hundreds of potential SH3 ligand proteins in cultured human cells to identify
preferred SH3-mediated interactions among the human proteome in a high throughput manner.
EXPERIMENTAL PROCEDURES

Generation of Expression Vectors Encoding Potential SH3 Ligand
Proteins—The 449 open reading frames (ORFs) of potential SH3
ligand proteins have been obtained from the Human ORFeome v3.1
library (34) as Gateway recombination-compatible entry constructs
(35) encoding full-length cDNA sequences of ORFs flanked by attL1
and attL2 sites required for site-specific recombination of the entry
clone with a Gateway destination vector. The Gateway-compatible
destination vector pEBB/PP-DEST has been generated by subcloning
a fragment from the modified pDEST vector (a kind gift from Jussi
Taipale, University of Helsinki, Finland), which encodes chloramphenicol resistance and ccdB genes flanked by recombination sites attR1
and attR2 into pEBB/PP vector (please contact authors for cloning
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details of this construct). The pEBB/PP vector is driven by the elongation factor 1␣ (EF-1␣) promoter, and contains a 123 amino acids
long biotin acceptor domain (19), to which we will refer as the “PP
domain” in the presented study. Recombination (Gateway LR) reactions between pEBB/PP-DEST and individual ORFs were performed
by using Gateway LR Clonase II Enzyme Mix (Invitrogen, Carlsbad,
CA) according to manufacturer’s recommendations. Each of the resultant pEBB/PP-ORF constructs encoded the desired ORF in frame
with PP domain sequence at the N terminus.
Protein Expressions and Streptavidin Coprecipitations—293FT
cells were transfected by standard calcium phosphate precipitation
method with pEBB/PP-ORF expression vectors or empty pEBB/PP
vector alone (control samples) corresponding to a total of 10 –16 g of
plasmid DNA per 10 cm culture dish. After 36 h of transfection, cells
were collected in PBG buffer (1⫻ phosphate buffered saline (PBS)
supplemented with 10% glycerol and 0.5% Tween-20) containing
protease inhibitors (“Complete,” Roche) and lysed by sonication at
0.2– 0.3 kJ on ice by Bandelin Sonoplus homogenizer. 2% aliquots of
the unprocessed lysate were used for Western blot analysis, where
the IRDye-labeled streptavidin was used for detection of expressed
proteins by Odyssey infrared imaging system (LI-COR Biosciences,
Lincoln, NE). The rest of the lysates were subjected to precipitation of
PP-ORF proteins using streptavidin-coated magnetic beads (Dynabeads M-280-Streptavidin, Invitrogen).
Phage Display—Panning of the SH3 phage display library using
target proteins was performed as described earlier (12). Briefly, precipitated PP-ligand fusion proteins were incubated with the mixture of
human SH3 library-displaying phages (109–1010 colony forming units
(cfu) per well), prepared in PBS-T (0.05% Tween-20 in 1⫻ PBS) and
supplemented with 2.5% of nonfat milk, for 2 h at room temperature.
The nonbound phages were then removed and the beads were
washed four times with 1 ml of PBS-T. Subsequently, phages bound
to PP-ligands were incubated with TG1 bacteria (grown to the logphase of OD600 ⫽ 0.5– 0.6) at 37 °C for 1 h followed by seeding of the
infected bacteria onto ampicillin-containing lysogeny broth (LB)
plates. Ligand-interacting SH3 domains were identified by sequencing of SH3 domain-encoding phagemides (pG8J8/SH3 clones (12)
obtained from individual bacterial colonies.
Peptide Array—Peptides of interest were synthesized by the Peptide and Protein Laboratory (Haartman Institute, University of Helsinki)
as peptide-cellulose conjugates using Multipep (Intavis Bioanalytical
Instruments, Cologne, Germany) according to the manufacturer’s
protocol for SPOT synthesis (36) and printed in parallel arrays on
glass slides using SlideSpotter equipment (Intavis Bioanalytical Instruments). The array was immersed for 2 h in Blocking solution
(PBS-T supplemented with 5% of nonfat dry milk) followed by washing three times in PBS-T. SH3 domains (Src, Lyn, Fyn, Yes, Tec, Crk,
CrkL, CMS (1/3), Amphiphysin (AMPH), BAIAP2L1, ArgBP2, Intersectin 1 (Itsn1) (3/5), Eps8L3) that had been identified as strong binders
to at least one of the ligand proteins were expressed in bacteria as
glutathione transferase- (GST-) fusions and purified by using affinity
chromatography. Individual GST-SH3 domains were diluted with
Blocking solution to a final concentration of 1 M and incubated with
peptide arrays for 2 h at room temperature, followed by three washes
with PBS-T and one wash with PBS. The binding was detected with
anti-GST antibodies conjugated with the near-fluorescent dye IRDye
800CW (LI-COR Biosciences) and quantified with an Odyssey Infrared
Imaging System (LI-COR Biosciences). The binding strength of the
SH3 domain for each of the arrayed peptides was estimated according to the obtained fluorescence intensity from the corresponding
spot in the array. The binding was rated as selective if the fluorescence signal was higher or about equal to 50% of the highest signal
intensity value estimated for the whole array.
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Pull-down Assay—The SH3 domains were expressed in bacteria as
GST-PP domain-fusions and purified as described above. The obtained protein solutions were dialyzed against Nonidet P-40 lysis
buffer (150 mM NaCl; 50 mM Tris-HCl, pH 7.4; 1% Nonidet P-40) and
adjusted to a final concentration of 0.5 M, supplemented with 500
M free biotin. An SH3 domain concentration of 0.5 M was chosen
because it was determined to be optimal for revealing relative differences in the capacity of different ligands proteins to capture different
SH3 domains in this setting. The SH3 ligand proteins were expressed
in HEK293T cells and immobilized to streptavidin-coated magnetic
beads as described above, except that after 1.5 h incubation of the
beads and lysates at 4 °C under rotation free biotin was added to a
final concentration of 500 M to saturate all biotin binding sites on the
beads, followed by three washes of the bead-protein complexes with
Nonidet P-40 lysis buffer. A bed volume of ⬃3 l of ligand proteincoated beads were added into each Eppendorf tube containing different dilutions of the GST-PP-SH3 proteins in 100 l of Nonidet P-40
lysis buffer supplemented with 500 M free biotin. This concentration
of free biotin was found to be efficient in preventing direct binding of
GST-PP-SH3 proteins to beads lacking preimmobilized SH3 ligands.
After incubation for 1 h at 4 °C under rotation the beads were washed
three times for 30 s with Nonidet P-40 lysis buffer. The proteins
associated with the beads after the washes were analyzed by SDSPAGE and Western blotting using IRDye800CW conjugated streptavidin. Detection was done using the Odyssey infrared imaging system
(LI-COR Biosciences). Background reduction and signal quantification were carried out using the Image Studio™Lite Software (LI-COR
Biosciences). For Scatchard analysis quantified signals for captured
SH3 domains were plotted against the ratio of these signals versus
the corresponding total concentration of SH3 domain used in the
pull-down. KD-values were generated by applying linear regression
model on the plotted data, whereas the slope of the regression line
corresponds to the negative value of the KD. Total [SH3] was used as
an approximation of free [SH3] for Scatchard analyses, which was
calculated to be adequate, because the amounts of ligands on the
beads were small, and only a minor fraction of total [SH3] was
removed from free [SH3] upon ligand binding.
RESULTS

Phage Display Library-based Screening of the Human SH3
Interactome—To investigate how commonly distinctly selective and robust SH3 interactions occur in the human interactome, and to identify such interactions in an unbiased manner
we set out to make use of our comprehensive SH3 domain
library to screen SH3 partners for a large number of potential
human SH3 ligand proteins predicted by sequence analysis.
As a source of these putative ligand proteins we used a large
human cDNA library, Human ORFeome v3.1, which contained
12,212 ORFs, representing 10,214 human genes, in a Gateway-cloning compatible vector backbone (34). The ORFeome
v3.1 library database was subjected to a bioinformatic search
for predicted SH3 target motifs using algorithms designed to
give a high likelihood for the selected ORFs to encode SH3
targets, but without any reference to the existing literature to
exclude or include previously reported SH3 interactions.
Two prediction strategies were employed for selection of
candidate cDNAs that were subsequently used to express
potential ligand proteins for screening of the SH3 library. In
the first approach, sequence search parameters were set to
identify both the conventional PxxP and unconventional mo-
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tifs, such as PxxDY, Px(P/A)xxR, ⌽xRPxR, and PxxxRxxKP
(where x is any amino acid and ⌽ is a hydrophobic residue).
We expected that this type of search would identify ligand
candidates with high probability of encoding actual SH3 binding proteins. As an alternative approach, we chose ORFs
based on the presence of proline- and basic amino acid-rich
regions, as well as randomly selected intracellular proteins
that had no suggestive SH3 binding motifs, but were involved
in cellular signal transduction and contained at least one
canonical protein interaction domain (SH3, SH2, or PDZ). We
hypothesized that while this second approach would be less
likely to identify functional SH3 ligands, it might lead to discovery of novel types of SH3 interactions. By combining these
two selection approaches, we identified 449 sequences in the
ORFeome v3.1 library database as the SH3 partner candidates for our screening (see supplemental Table S1). Of these
proteins 302 contained at least one conventional type I or type
II SH3 binding motif, R/Kx⌽PxxP and Px⌽PxR/K, respectively.
The 449 selected ORFs were subjected to subcloning into a
Gateway-compatible destination vector pEBB/PP-DEST generated for this purpose (see Experimental Procedures). pEBB/
PP-DEST is driven by the elongation factor 1 (EF-1␣) promoter, and contains a 123 amino acids long biotin acceptor
domain (“PP domain”; (19)) plus Gateway destination sequence attR1-ccdB-attR2 for recombination with ORF-encoding sequences and bacterial selection of recombinant
clones. The putative ligand proteins were transiently expressed as biotinylated PP-fusion proteins in human embryonic kidney 293T cells (HEK293T), and immobilized onto
streptavidin-coated paramagnetic beads for a single round
affinity panning of the SH3 phage library. An illustrated outline
of this approach is shown in Fig. 1.
As summarized in Table I, 324 ORFs out of the initial 449
clones could be successfully subcloned and expressed as
expectedly sized proteins in HEK293T cells (for a complete
list, see supplemental Table S1). Expression of PP domaincarrying ORFs was monitored by subjecting lysates to Western blotting using streptavidin labeled with an infrared dye.
Successful expression was verified by comparing the Western
blot signals of the ORFs with a control protein lysate stock
containing a PP-fusion of p21-activated kinase-2 (PAK2; Fig.
1). In earlier experiments we had confirmed that a reproducible selection of the same set of SH3 domains could be
achieved over a wide range of PP-PAK2 expression levels
(data not shown). A PP-PAK2-containg control lysate stock
was used as a concentration standard to confirm an acceptable ORF expression by the individual PP-fusion clones,
which was defined as a streptavidin blotting signal that was
stronger than the signal observed for the lowest PP-PAK2
concentration that could still support robust and specific SH3
phage selection.
Of the 324 successfully expressed proteins 19 (5.6%)
showed strong and selective SH3 binding, which was defined
as ⬎20-fold enrichment of infectious phages compared with
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FIG. 1. Schematic outline of the experimental strategy used.
Biotinylation domain (PP)-tagged putative ligand proteins were expressed by transient transfection, and immobilized onto streptavidincoated paramagnetic beads. Subsequently a comprehensive library
of human SH3 domain-expressing phages (296 different ones) was
incubated with the potential ligand, followed by washing off the
unbound phages, and infection of bacteria with the captured phages,
and identification of these SH3 clones by DNA sequencing.
TABLE I
Statistics of ORF expression and library screening results
Total number of ORFs selected for the study

449

ORFs successfully expressed and tested
● Strong and selective SH3 binders
● Significant binding but modest selectivity
● Poor or no binding

324
19
25
298

mock panning (using control beads coated with an empty
PP-domain only), and dominant selection of a just single or
only a small number of individual SH3 domains. Significant
enrichment of phages (between three- to 20-fold) samples
associated with a lower SH3 binding selectivity was observed
for another group of 25 proteins (7.7%). No significant SH3
binding and/or lack of specificity was observed for the remaining proteins, thus representing the majority (86%) of all
the ORFs examined.
The 19 strong and selective SH3 ligands that we identified
are listed in Table II together with their preferred SH3 partners
revealed by the screen. Considering the unbiased selection
strategy of the putative SH3 target proteins included in the
screen, it was encouraging to find that these 19 best hits
included some already described SH3-mediated proteins interactions that are known to involve distinctly high binding
affinity and selectivity, namely the complex between GRB2related adaptor protein downstream of Shc (GADS aka Mona)
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and Src homology 2 domain-containing leukocyte phosphoprotein of 76 kDa (SLP-76 aka LCP2) (37, 38) and Hematopoietic cell-specific Lyn substrate 1 (HCLS1) interaction with
the SH3 domain of Lyn (39).
However, the majority of the interactions that we discovered were novel. As evident from Table II, the robust enrichment of SH3 clones from the phage library was in most cases
also associated with distinct selectivity. For example, the
phage clones selected by HCLS1, Insulin receptor tyrosine
kinase substrate (IRTKS), and Calcium/calmodulin-dependent
protein kinase type IV (CAMK4) all involved only a single SH3
domain specific to these ligand proteins (Lyn, Eps8L3, and
Btk, respectively). The single most preferred SH3 domain
comprised 50% or more of the selected clones in 17 (out of
19) cases, and in the two remaining cases, namely Arg/Ablinteracting protein (ArgBP2) and Embryonal Fyn-associated
substrate (EFS), half or more of the clones represented only
two different SH3 domains. Of note, in several cases independent infectious preparations of the SH3 phage library were
screened using independently prepared ligand proteins, confirming an excellent reproducibility of this. The data from such
sub-screens for seven of the 19 ligand proteins listed in Table
II are provided in supplemental Table S2.
Functional Characterization of the Target Peptides in the
SH3 Ligand Proteins—To investigate the role of individual
proline-rich motifs in SH3 binding by the 19 highly selective
ligand proteins we synthetized 65 different peptides derived
from these proteins (Table III). These peptide sequences were
15 to 17 residues in length, and overlapped with the predicted
motifs that originally served as the criteria for selecting the
corresponding proteins from the ORFeome v3.1 library. The
number of potential target peptides contained in each ligand
protein varied greatly, ranging from 1 (e.g. AMPH) to 12
(WIPF1).
These 65 peptides were spotted on glass slides and probed
with 16 different SH3 domains, fused to the glutathione transferase (GST), including most of the SH3 domain that were
highly selected from the phage library by at least one of target
proteins. Some phage display-selected SH3 domains (GADS,
Eps8L3, and Btk) could not be used because they were poorly
expressed as recombinant proteins or showed nonspecific
binding to the slides. To compensate for the lack of Eps8L3,
the homologous SH3 domain of Eps8L1 was included as
probe in these experiments. The most suitable concentration
of the GST-SH3 proteins for probing of these arrays was
empirically established as being 1 M, which ensured the
optimal peptide binding signal ratio over the background
noise. Two different spatial spotting schemes were printed on
each slide in order to exclude any position-related bias from
the array signals, and three sets of 2 ⫻ 65 spotted peptides
were probed with each SH3 domain. Representative sets of
raw data from probing of these arrays with three different SH3
domains are shown in Fig. 2.
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TABLE II
Strong and selective SH3-binding ORFs and their SH3 partner preference
Ligand

Gene name(s)

Hematopoietic cell-specific Lyn substrate
Insulin receptor tyrosine kinase substrate
Calcium/calmodulin-dependent protein kinase type IV
SH2 domain containing leukocyte protein of 76kDa

HCLS1, HS1
IRTKS, BAIAP2L1
CAMK4
SLP76, LCP2

c-Cbl-interacting protein of 85 kDa

CIN85, SH3KBP1

SH2-B homolog

SH2B, PSM

Neutrophil cytosolic factor 2

NCF2, p67phox

Neutrophil cytosolic factor 1

NCF1, p47phox

Arg/Abl-interacting protein

ArgBP2, SORBS2

Amphiphysin1

AMPH

Testis-specific kinase 1

TESK1

SH3 domain containing, Ysc84-like 1

SH3YL1

PDZ domain containing 8

PDZK8

Embryonal Fyn-associated substrate

EFS, SIN

PHD finger protein 21B

PHF21 B

DENN domain-containing protein 1A

DENND1A

Signal transduction protein CBL-C

CBLC, CBL-3

WAS/WASL interacting protein family, member 1

WIPF1, WASPIP

ArfGAP with SH3 domain, ankyrin repeat and PH domain 2

ASAP2, AMAP2, DDEF2, PAG3

3274

Target SH3

Share (%)

Lyn
Eps8L3
Btk
GADS (2/2)
Intersectin-1 (3/5)
Amphiphysin
SH3YL1
Crk (1/2)
CrkL (1/2)
Lyn
SH3YL1
Ponsin (2/3)
ArgBP2 (2/3)
IRTKS
Tec
AHI-1
OSTF1
Ponsin (2/3)
SH3YL1
POSH (4/4)
Tec
NBL1
CMS (1/3)
Tec
AHI-1
Src
Lyn
ArgBP2 (2/3)
Ponsin (2/3)
ARHGEF37 (2/2)
Src
OSTF1
FISH (3/5)
Src
CMS (1/3)
Intersectin-1 (3/5)
Intersectin-2 (3/5)
Src
Yes
Btk
Nephrocystin
Tec
Src
Fyn
Nephrocystin
CrkL (1/2)
Amphiphysin
Tec
SH3YL1
Intersectin-1 (3/5)
Src
Btk
Lyn
Tec
Src
Btk
Intersectin-1 (3/5)

100
100
100
90
10
60
20
13
7
64
36
75
13
6
6
42
23
15
8
4
4
4
35
25
15
15
10
58
42
63
13
13
13
69
31
88
13
25
25
25
13
13
43
43
14
71
29
75
13
13
63
13
13
13
71
14
14
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TABLE III
Summary of the peptide array data. The sequences of the arrayed peptides covering the potential target motifs in the 19 ligand proteins are
shown, and the relative intensity of their binding to the 16 SH3 domains used as probes is indicated. The binding intensity values are highlighted
according to the categories described in the text (strong ⫽ pink, intermediate ⫽ orange, weak ⫽ grey, negative ⫽ no color). The binding values
for peptides derived from ligand proteins that specifically selected the corresponding SH3 domain from the phage library are boxed, indicating
⬎5% (black square) or ⬎50% (blue square) proportion of all the SH3 domains selected by this ligand protein. The IRTKS peptide is circled in
blue for EpsL1-SH3, although the highly selected SH3 domain for IRTKS was the closely related Eps8L3, which was not available as a probe.
Other highly selected SH3 domains that could not be produced as a high quality probes were Btk, ponsin (2/3), GADS (2/2), and ARHGEF37

Molecular & Cellular Proteomics 15.10
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FIG. 2. Raw data from probing of the peptide arrays with three
different SH3 domains. The 65 peptides were spotted using two
different schemes and probed with the indicated GST-tagged SH3
domains, followed by detection of binding with a labeled anti-GST
antibody.

Because of the nature of this experimental approach, a
direct comparison of the absolute binding signals obtained
from probing of the peptide array slides with different GSTSH3 probes would not be informative. Instead, we compared
the relative peptide binding signals measured for each SH3
domain. After subtracting background fluorescence values
from the peptide spot signals, the SH3 binding intensity value
of each peptide was calculated relative to the average signal
of all the peptides in the same array (see Table III).
For discussion purposes we divided the relative SH3 binding by these peptides into four categories; negative, weak,
intermediate, and strong. Signals that were below the half of
the average (⬍0.5) of all the peptides were scored as “negative.” Signals that were 0.50 – 0.99 times the average were
scored as “weak,” 1.0 –1.99 times the average as “intermediate,” and twice the average or higher (⬎2) as “strong.” Depending on the SH3 domain used as a probe 4.6 –23.1%
(3–15 out of 65) of the peptides scored as strong binders,
6.2– 43.1% (4 –28) as intermediate binders, 4.6 –36.9% (3–24)
as weak binders, and 26.2– 69.2% (17– 45) as “negative.”
These differences reflected the variable peptide binding selectivity of the different SH3 domains tested, but to some
extent also the experimental signal to noise ratio determined
by the technical quality of the individual GST-SH3 probes. In
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the case of a highly selective binder, such as Eps8L1 SH3, the
strongest signal was more than 10 times the average,
whereas this ratio was less than 3 for some SH3 domains,
such as amphiphysin.
The 65 putative target peptides varied greatly in their relative specificity as SH3 targets. Some peptides were highly
promiscuous in SH3 binding. Ten of these peptides were
good binders (strong or intermediate) for more than 80% of
the SH3 domains (at least 13 of the 16 SH3 probes), including
three peptides (ISQIRPPPLPPQPPSRLP, LSAPPLPPRPDLPPRKPR and KGSIQDRPLPPPPPRLPG from ASAP2, CBLC,
and EFS respectively), which scored as strong binders for all
SH3 domains except amphiphysin. On the other hand, many
peptides showed distinct SH3 selectivity. More than a third of
the peptides (n ⫽ 24; 37%) were strong or intermediate binders for only three or fewer of the 16 SH3 probes, including six
peptides with strong binding to one or two SH3 domains, but
weak or negative binding to the remaining 14 SH3 domains.
The highest specificity was presented by the peptide ENSSVVIPPPDYLECLSM from IRTKS that bound very intensely
(more than 10 times average) to Eps8L1, but scored negative
for all other SH3 domains. Although this specificity agrees
well with the known preference of the Eps8-family SH3 domains for PxxDY motif-containing ligands (9), it is interesting
to note that within this family Eps8L3 SH3 appears to be the
superior binder for native IRTKS protein, as it was able to
outcompete other SH3 domains in the library (including
Eps8L1) and alone dominate the screening results. Other
examples of peptides showing strong and selective binding
were the ArgBP2 SH3#2 binder HPLTRVAPQPPGEDDAPY
(from Efs), the CMS SH3 (1/3) binder DSLPVAPGRDRPPKQPPT (from PHF21B), the CIN85 SH3 (1/3) binder NYKIRFKPFFPYQTLQGF (from PDZK8), and the CrkL and CMS SH3
(1/3) binder QKPSVPAIPPKKPRPPKT (from CIN85). Fourteen
peptides (22%) did not show higher than average binding to
any SH3 probe, but of note, only three (4.6%) scored negative
for all SH3 domains.
As might be expected, the phage library screening and the
peptide array binding data sets showed some correlation with
each other. At least one peptide with stronger than average
binding to an SH3 domain was more often present than
lacking in ligand proteins that had affinity-selected the same
SH3 domain from the phage library. However, considering
that almost half of the ligand proteins contained one or more
peptides showing strong and highly promiscuous SH3 binding this overlap is not very striking. Indeed, if the six most
promiscuous peptides in the array (from ASAP2, Efs, CBLC,
PDZK8) that dominated the top scoring SH3 target peptide
lists were excluded, only two peptides derived from their
preferred native ligand proteins could be found among the
strongest 10% binding peptides for the same SH3 domains.
These were ENSSVVIPPPDYLECLSM from IRTKS and
QKPSVPAIPPKKPRPPKT from CIN85, which were the best
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and the third best binding peptides of Eps8L1 SH3 and CrkL
SH3 (1/2), respectively.
On the other hand, several ligand proteins that showed
strong selection of individual SH3 domains from the phage
library did not contain a peptide capable of higher than average binding to these SH3 domains. A striking example of this
was PHF21B that preferentially selected Fyn and Src SH3
domains as its partners from the phage library. PHF21B contains a single proline-rich motif (DSLPVAPGRDRPPKQPPT)
that in the peptide array showed strong (almost five times the
average) and highly selective binding to CMS SH3 (1/3), but
was negative for Fyn and Src.
In summary, based on the divergent and reproducible binding patterns obtained with different SH3 probes, together with
the low proportion of peptides failing to show any SH3 binding
we conclude that the technical quality of these peptide array
data was good. Nevertheless, the binding strength of individual SH3 interaction motifs failed to predict preferred partnerships revealed by these ligand proteins in their native form.
Semiquantitative Analysis of the Strength of Selected SH3ligand Protein Interactions—Because the strong and preferred
SH3 interactions identified by phage library screening correlated poorly with SH3 binding selectivity of short linear peptides derived from the same target proteins it was of interest
to study binding of these ligand proteins to SH3 domains in
solution. Such studies were also necessary to substantiate
our premise that robust and dominant interactions revealed
by screening of the SH3 proteome phage library involve significantly higher binding affinities than those reported for most
SH3 interactions.
To address these issues we established a semiquantitative
pull-down assay where paramagnetic streptavidin beads
coated with biotin-tagged ligand proteins derived from human
293T cells were incubated with known concentrations of recombinant SH3 domains. In preparatory experiments (not
shown) we first tested and validated this assay system the
amounts of SH3 captured by HIV-1 Nef-coated beads incubated with serial dilutions of Hck SH3 were examined by
Scatchard analysis, which gave a KD value of 189 nM matching relatively closely the value of 250 nM previously established for this high-affinity SH3 interaction in proper quantitative measurements (10, 11). Thus, despite the limitations of
this semiquantitative system, involving beads densely coated
with the ligand and a non-equilibrium incubation phase (i.e.
including washes) it was found to be adequate for estimating
of binding affinities, at least for strong (submicromolar range)
SH3 interactions.
Four ligand proteins (SH3YL1, SH2B, DENND1A, and
PHF21B) that in phage library screening showed different
binding preferences toward the SH3 domains of Src, Lyn,
CrkL, and Fyn (Fig. 3A) were chosen for comparison. Similar
to the library screening (see Fig. 1) these ligands were expressed as native, biotinylation domain-tagged proteins in
human cells, and immobilized on paramagnetic beads. When
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beads coated with SH3YL1 were incubated with soluble Src,
Lyn, CrkL, and Fyn SH3 domains at a 500 nM concentration,
washed, and examined for the associated SH3 domains, a
highly preferential binding to Src-SH3 was observed, whereas
only weak binding to the three other SH3 domains was observed, (Fig. 3B).
This agreed well with the preferential (69%) selection of Src
SH3-displaying phage clones in the library screen, and is
striking also when considering that Lyn and Fyn belong to
the same Src-family of SH3 domains, and are known to prefer
similar core SH3 binding motifs (40). Likewise, a clearly preferential pull-down of Lyn-SH3 was observed for SH2B (Fig.
3C), which in the SH3 phage screening showed exclusive
selection (100%) of Lyn as its binding partner. DENND1A that
showed 71% selection of CrkL SH3 in phage screening also
preferentially associated with CrkL in this pull-down comparison, although its selectivity at the 500 nM SH3 concentration
tested was less striking than observed for SH3YL1 and SH2B.
However, considering that DENND1A does not contain a peptide showing even intermediate level binding to CrkL SH3, this
agreement with the preference of native DENND1A for CrkL
observed in phage screening is remarkable. Finally, PHF21B
that preferred Src as well as Fyn SH3 domain (both 43% of
selected clones) in library screens, also bound to these two
SH3 domains more strongly than to Lyn or CrkL. In conclusion, the results obtained in this pull-down assay including
four SH3 ligand proteins versus four selected SH3 domains
correlated well with the binding preferences identified for
these native ligands, but agreed poorly with the peptide array
data, and in some cases (for example PHF21B) even contrasted the SH3 binding profiles of isolated proline-rich peptides from the same proteins.
To estimate the binding affinity involved in the dominant
SH3 - ligand partnerships revealed by the SH3 library screens
we chose two such interactions for more detailed analyses.
One was binding of HCLS1 to Lyn-SH3, which similar to the
SH2B/Lyn interaction was suggested to be of high affinity by
the exclusive affinity selection of Lyn-SH3 by HCLS1 from the
phage library. The other one was the SH3YL1/Src-SH3 interaction, which appeared to be particularly strong when examined for its selectivity in Fig. 3B. Dilution series of Lyn and Src
SH3 domains were incubated with beads coated with their
cognate ligand proteins, and their association with HCLS1
and SH3YL1 was examined with the pull-down assay described above (Figs. 3F and 3G). When the capacity of HCLS1
and SH3YL1 to capture Lyn and Src SH3 domains provided at
different concentrations was quantified and examined by
Scatchard analysis (Fig. 3H), submicromolar affinity values
indicative of exceptionally tight SH3 binding could be determined. The KD value of the HCLS1/Lyn-SH3 interaction was
estimated to be 746 nM, whereas an affinity as high as 187 nM
was found for the SH3YL1/Src-SH3 complex. By contrast,
when binding of HCLS1 to Fyn-SH3 was tested an affinity of
only 7 M was measured (supplemental Fig. S1).
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FIG. 3. Selectivity and affinity of
binding of four selected ligand proteins to recombinant SH3 domains in
solution. A, The quality and concentration of purified Src, Lyn, Fyn. and CrkL
SH3 domains expressed as biotinylated
GST fusion proteins in E. coli were confirmed by running a calculated 50 ng of
each in SDS-PAGE followed by Western
blotting (B to E). The SH3 ligand proteins
SH3YL1 (A), SH2B (B), DENND1A (C),
and PHF21B (D) were expressed in
human 293T cells by transient transfection, and immobilized on paramagnetic
beads. These ligand-coated beads were
added to a control tube (-) and to tubes
containing a 500 nM solution of Src, Lyn,
Fyn, or CrkL SH3. After incubation the
beads were washed to remove unbound
SH3, followed by analysis of the coated
ligand proteins and the associated SH3
domains by SDS-PAGE and Western
blotting. The intensities of the specific
ligand-captured SH3 signals were quantified, and are shown above the corresponding blots as bar graphs where the
strongest signal has been normalized to
a value of 100 (F and G). Aliquots of
beads coated with HCLS1 (F) or SH3YL1
(G) as described above were similarly
incubated with increasing concentrations (from 0 to 4 M) of Lyn-SH3 (F) or
Src-SH3 (G), followed by analysis and
quantification of ligand-bound SH3 domains as above. H, The signal intensities
of the specifically captured SH3 domains were examined by Scatchard
analysis to derive the indicated KD values for the HCLS1/Lyn-SH3 and the
SH3YL1/Src-SH3 interactions. The R2
values describing the goodness of fit for
the data points in the Scatchard analysis
were 0.9035 and 0.9256, respectively.

Together these semi-quantitative interaction data support
the validity of our phage library results and the notion that
these screens can provide novel examples of high affinity SH3
interactions where the binding strength and specificity cannot
be recapitulated by short linear peptide ligands.
DISCUSSION

In this study we have made use of a phage display library
that contains a near complete collection of human SH3 domains to carry out a large-scale protein interaction screen
involving hundreds of potential human SH3 ligand proteins. A
key objective of our study was to systematically examine how
commonly strong and selective interactions occur among the
human “SH3 interactome.” In addition, identification of such
robust SH3 interactions could provide valuable new leads for
research aimed at unraveling signaling protein networks that
regulate cell behavior.
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The use of full-length ligand proteins in this study ensured
that complex interactions involving binding determinant outside of the predicted SH3 target site would not be missed. To
make sure that these full-length proteins are produced and
folded properly, we produced them in mammalian (HEK293T)
cells. Of the total 449 potential SH3 ligand proteins predicted
from the human genome 324 could be produced successfully
as judged by an expectedly sized Western blotting signal with
an acceptable intensity.
The phage library that we used has previously proven its
value in identifying high-affinity SH3 partners for a number of
cellular and pathogen-encoded ligand proteins (12–25). These
studies have established the positive predictive value of the
hits generated by this screening method to be remarkably
high, i.e. the preferred SH3-ligand partnerships revealed by
the library screens have reliable indicated cellular interactions
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that have subsequently been readily verified biochemically/
functionally. In part, this success can be explained by the
inherent feature of this experimental system of failing to detect SH3 interactions with low/modest affinity. Although many
weak but potentially relevant interactions may thus be missed,
the false discovery rate remains low. For example, although
the HIV Nef protein is well documented to interact with the
Src-family kinase SH3 domains Lck and Fyn (affinities 10.6 M
and 15.8 M; (41)), only the high-affinity SH3 partners Hck
(affinity 0.25 M; (10)) and Lyn were identified as ligands for
Nef using this approach ((12) and unpublished data). Conversely, the binding affinities measured for the specific interactions that we have identified have been in the low micromolar range or better (10, 42), and unpublished data).
Despite the relatively high predicted likelihood of the 324
proteins included in the current study to encode functional
SH3 ligand proteins, significant enrichment of SH3-displaying
phages from the library was observed only for 44 of them
(13.6%), and only for 19 (5.6%) a distinct preference for
individual SH3 domains could be seen. Although it is not
possible to know how many of the examined ORFs actually
encode bona fide SH3 ligands, we can conclude that strong
and distinctly selective partnerships are relatively rare among
SH3-mediated human protein interactions. This conclusion is
in agreement with the fact that the majority of SH3 interactions described in the literature are relatively weak. Indeed, it
has been proposed that low affinity and modest to poor
selectivity are characteristic features of SH3 binding (43).
Thus, the specificity of the cellular processes that these interactions regulate may be provided mainly by other contributing factors that our SH3 library approach would miss, such
as further cooperative contacts between the SH3-containing
protein and its ligand, additional interacting proteins participating in the same multiprotein complex, as well as subcellular compartmentalization.
On the other hand, despite forming a minority, our current
data show that SH3 interactions with a high affinity and specificity do exist at a reasonable frequency. Using a semiquantitative interaction assay we could establish submicromolar
affinities and a remarkably high selectivity in binding even to
closely related SH3 domains for the dominant SH3 phage
library-discovered interactions that we examined. Thus, our
data suggest that in some instances SH3 binding could also
play a major role in determining protein interaction partnerships, and in driving the assembly of specific protein complexes in cells. Structural analyses of such robust SH3 interactions described earlier have shown that when compared
with typical SH3-ligand complexes they involve extended target peptides or even more complex binding determinants
within the ligand protein, which cover a larger surface on the
cognate SH3 domains (Nef/Hck-SH3 (11), p47hox/p67hox-SH3
(44), PEP/Csk-SH3 (45); PAK/␤PIX (46, 47), SLP-76/GADSSH3 (37, 38), and EspFU/IRTKS-SH3 (42)).
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A similar complex mode of binding is likely to be the case
also with many or most of the SH3 interactions identified in
this study. Supporting this notion, the SH3 binding intensity of
the linear target motifs examined on our peptide array failed
almost completely to explain the SH3 binding selectivity observed for the corresponding native target proteins in the phage
library screen. The strongest peptide binding signals did not
predict SH3 partners selected by the host proteins of these
peptides. By contrast, in some cases SH3 domains that were
highly preferred by certain ligand proteins failed to show significant binding to any peptide derived from this protein, although
the same peptides bound well to other SH3 domain probes.
When considering the relative SH3 binding selectivity of the
arrayed peptides rather than absolute strength of binding a
somewhat better overlap between the two data sets could be
seen. The IRTKS- and CIN85-derived peptides not only bound
strongly but were unusually selective for Eps8L1 SH3 and
CrkL SH3 (1/2), respectively. Likewise, HCLS1 and SH2B1
that predominantly selected Lyn SH3 from the phage library
both contained a peptide that showed strong binding only to
Lyn (EDNEEPPALPPRTLEGLQ and DSMELLPPELPPRIPIEE,
respectively). Moreover, the preference of ArgBP2 for CIN85
SH3 (1/3) in phage-display could be correlated with the presence of the peptide PPPLPTTPTPVPREPGRK in ArgBP2 that
bound strongly only to CIN85 SH3 (1/3) and CMS SH3 (1/3),
but poorly to all other SH3 domains used as probes. Despite
the high technical quality of the peptide array, however, apart
from these few examples the peptide binding data were not
generally helpful in explaining the SH3 selectivity shown by
the corresponding native proteins in phage display.
Thus, we conclude that the SH3 selectivity of the 19 native
protein ligands examined in this study is either based on
binding determinants that are located outside of the core SH3
binding motifs contained in the arrayed peptides, or alternatively, are dependent on a particular conformation of the
peptide that is lost when it is no longer presented as a part of
the corresponding folded protein. In either case, our data
suggest that large-scale peptide arrays screens have relatively limited value for attempts to characterize relevant SH3mediated protein interaction networks in cells.
It is pertinent to compare our current approach to the
previously reported SH3 interactome studies that have been
based on large-scale Y2H combined with extensive peptide
library screens (30, 31, 33). These authors concluded that Y2H
and peptide array screens query different but overlapping
regions of protein-protein interaction (PPI) space. Mapping of
the SH3 interactome using Y2H resembles our approach in
that it involves the use of folded ligand proteins rather than
short target peptides. On the other, it differs from our phage
display screening approach in involving more confounding
biological variables other than binding affinity, and thereby
may also identify weak or false interactions as “hits.” It has
been suggested that the predictive value of such large-scale
screens could be increased by integrating the data from Y2H
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and peptide array screens, i.e. considering only interactions
indicated by both approaches. However, in light of our current
data, ignoring strong SH3-protein interactions that are not
matched by a strong SH3-peptide interaction would not seem
like a good strategy. Such filtering would probably bias the
results toward a subpopulation of interactions that involve
atypical peptide binding motifs (such as the IRTKS - Eps8L1/3
interaction identified here), but would miss all interactions that
are strong and selective despite involving a typical low-affinity
SH3 binding core motif.
As already noted above, our SH3 phage display screening
approach involves a relatively high affinity threshold for interaction identification. Because it also involves competition for
ligand binding by an essentially complete repertoire of human
SH3 domains it is indeed well suited for discovery of strong
and selective SH3 interactions. Although it is logical to assume that such interactions have a high likelihood of being
relevant, it is also clear that this kind of a binding profile alone
does not establish biological significance. On the other hand,
it is important to note that the reverse is also true, and lack of
high binding affinity and apparent specificity of an SH3/ligand
interaction studied in isolation do not exclude a major role in
cellular regulation. In any case, the strong and selective interactions identified here using 324 predicted SH3 ligand proteins provide a valuable collection of novel interactions that
may regulate cell behavior and potentially reveal new targets
for therapeutic development. In Table II 57 such interactions
involving 19 different target proteins are listed, most of which
represent interactions that have not been described before.
Several of these suggest interesting and readily testable hypotheses of potential medical importance.
For example, a novel regulatory circuit operative in reactive
oxygen species (ROS) production and neutrophil phagosome
function that is relevant to pathogen defenses and chronic
granulomatous disease (see (48)) is suggested by the interactions between the second (of three) SH3 domains of Ponsin
and ArgBP2 with the NCF1 (p47-phox) and NCF2 (p67-phox)
regulatory subunits of the NOX2 neutrophil NADPH oxidase
complex. Ponsin (SORBS1) and ArgBP2 (SORBS2) are signaling factors that together with vinexin (SORBS3) form the
SoHo family of adapter proteins (49). Our previous SH3 interaction screens have revealed binding of the third SH3 of the
SoHo proteins to the p21-activated kinase (PAK) (12), an
interaction that is also independently supported by cell biology studies (50). Because PAK acts as an activator of NADPH
oxidase complex and ROS production by phosphorylating
NCF1 (51), our studies suggest an important role for the
ArgBP2 and ponsin adapter proteins as signaling platforms
that coordinate NADPH oxidase complex activation via their
dual capacity to bind NADPH subunits (via SH3 (2/3)) and PAK
(via SH3 (3/3)). In support of this possibility, we have observed
that NOX2-mediated ROS production is inhibited in cells overexpressing an ArgBP2 variant carrying an inactivating mutation in its third SH3 domain (unpublished data).
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Further characterization of biological significance of the
novel SH3 interactions revealed in our screen is clearly warranted. Also, despite the relatively low “hit rate” in this study,
extension of the current study to even higher numbers of
potential human ligands predicted by algorithms similar those
used here as well as modified ones would seem like a worthwhile endeavor. However, in order to achieve the goal of
comprehensive characterization of the human SH3 interactome, novel high-throughput methods based on functional
read-outs rather than affinity ranking of SH3-ligand interactions will also be needed.
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